ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,631
Screening encounters
2,928
Diagnostic referrals
572
Outstanding pathways
226

Screening pathway

  1. Screening2,928Encounters
  2. Positive finding1,003Documented findings
  3. Referral572Diagnostic referrals
  4. Follow-up649Diagnostic visits
  5. Outcome346Resolved pathways

Stage totals use different units. Pending pathways: 226. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3202 · EXP-3202Synthetic · Site E

Full participant history through 2026-04-16, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-05-27
  4. · Diagnostic referral · EXP-3202-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Transport difficulty
  8. · Diagnostic visit · Attended
  9. · Diagnosis · Colposcopy · Biopsy collected
  10. · Navigation intervention · Coordination support
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-01-14
  13. · Follow-up disposition · Resolved · EXP-3202-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2631 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2930 · Expanded synthetic participant 2930Site B — Peri-Urban Access Programme
EXP-2935 · Expanded synthetic participant 2935Site A — Urban Referral Hub
EXP-2936 · Expanded synthetic participant 2936Site C — Rural Outreach Programme
EXP-2938 · Expanded synthetic participant 2938Site C — Rural Outreach Programme
EXP-2939 · Expanded synthetic participant 2939Site A — Urban Referral Hub
EXP-2944 · Expanded synthetic participant 2944Site B — Peri-Urban Access Programme
EXP-2947 · Expanded synthetic participant 2947Site E — Resource-Constrained Navigation Programme
EXP-2948 · Expanded synthetic participant 2948Site A — Urban Referral Hub
EXP-2949 · Expanded synthetic participant 2949Site B — Peri-Urban Access Programme
EXP-2950 · Expanded synthetic participant 2950Site D — Community Engagement Programme
EXP-2953 · Expanded synthetic participant 2953Site E — Resource-Constrained Navigation Programme
EXP-2955 · Expanded synthetic participant 2955Site B — Peri-Urban Access Programme
EXP-2956 · Expanded synthetic participant 2956Site C — Rural Outreach Programme
EXP-2959 · Expanded synthetic participant 2959Site C — Rural Outreach Programme
EXP-2960 · Expanded synthetic participant 2960Site B — Peri-Urban Access Programme
EXP-2961 · Expanded synthetic participant 2961Site E — Resource-Constrained Navigation Programme
EXP-2962 · Expanded synthetic participant 2962Site E — Resource-Constrained Navigation Programme
EXP-2964 · Expanded synthetic participant 2964Site A — Urban Referral Hub
EXP-2969 · Expanded synthetic participant 2969Site D — Community Engagement Programme
EXP-2972 · Expanded synthetic participant 2972Site A — Urban Referral Hub
EXP-2973 · Expanded synthetic participant 2973Site B — Peri-Urban Access Programme
EXP-2976 · Expanded synthetic participant 2976Site E — Resource-Constrained Navigation Programme
EXP-2980 · Expanded synthetic participant 2980Site E — Resource-Constrained Navigation Programme
EXP-2987 · Expanded synthetic participant 2987Site E — Resource-Constrained Navigation Programme
EXP-2988 · Expanded synthetic participant 2988Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1203
HPV DNA
1289
Cytology
436

Navigation activity

Barrier documented
481
Contact attempt
836
Navigation intervention
207
Diagnostic booking
705
Diagnostic visit
649

Documented barriers

Contact difficulty
156
Transport difficulty
149
Appointment coordination
176

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.